CSI Market
Sign In | Register

Precision Biosciences Inc (DTIL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DTIL Annual Balance Sheets →
The data below summarizes Precision Biosciences Inc's balance sheet position from Sep 30 2025 to Sep 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DTIL/balance-sheets
https://api.csimarket.com/api/v1/companies/DTIL/fundamentals
https://api.csimarket.com/api/v1/companies/DTIL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent81.70
Restricted Cash26.34
Marketable Securities, Current SH0.15
Cash & Short-term Investments81.00
Accounts receivable0.00
Financing Receivable, Net, Total NO0.00
Other Current Assets0.00
Prepaid Expense, Current AS4.72
Total Current Assets86.58
Equipment/Property/Plant Net0.78
Intangible Assets1.06
Long-term investments0.00
Other Assets, Noncurrent5.63
Assets Held For Sale Not Part Of Disposal Group Current-
Operating Lease Right Of Use Asset5.46
Total Assets120.38
Liabilities
Accounts Payable, Current AC0.81
Employee-related Liabilities, Current AC3.48
Financial Instruments23.97
Other Liabilities, Current0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities8.27
Long-term debt22.42
Total Long-term Debt22.42
Other liabilities, Noncurrent17.92
Operating Lease Liability Current1.56
Contract With Customer Liability Current-
Contract With Customer Liability Noncurrent-
Operating Lease Liability Noncurrent4.49
Total Liabilities68.60
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.95
Additional Paid In Capital Common Stock639.59
Retained Earnings / Accumulated Deficit-586.87
Defined Benefit Plan and Other23.97
Other Equity0.00
Common Stockholder's Equity51.78
Total Stockholder's Equity51.78
Liabilities & Stockholder's Equity120.38
4 historic quarters locked

Sign in to unlock the full Precision Biosciences Inc balance sheet history.

Sign In Create Free Account

About Precision Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-069092

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI